Grummet J, Gorin MA, Popert R, O’Brien T, Lamb AD, Hadaschik B, et al. “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now. Prostate Cancer Prostatic Dis. 2020;23:62–5.

Article  PubMed  PubMed Central  Google Scholar 

Newman TH, Stroman L, Hadjipavlou M, Haque A, Rusere J, Chan K, et al. EXIT from TRansrectal prostate biopsies (TREXIT): sepsis rates of transrectal biopsy with rectal swab culture guided antimicrobials versus freehand transperineal biopsy. Prostate Cancer Prostatic Dis. 2022;25:283–7.

Article  CAS  PubMed  Google Scholar 

Mian BM, Feustel PJ, Aziz A, Kaufman RP, Bernstein A, Avulova S, et al. Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial. J Urol. 2024;211:205–13.

Article  PubMed  Google Scholar 

Mian BM, Kaufman RP, Fisher HAG. Rationale and protocol for randomized study of transrectal and transperineal prostate biopsy efficacy and complications (ProBE-PC study). Prostate Cancer Prostatic Dis. 2021;24:688–96.

Article  PubMed  Google Scholar 

Hu JC, Assel M, Allaf ME, Ehdaie B, Vickers AJ, Cohen AJ, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024.

Hu J, Zhu A, Vickers A, Allaf ME, Ehdaie B, Schaeffer A, et al. Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplications. BMJ Open. 2023;13:e071191.

Article  PubMed  PubMed Central  Google Scholar 

Jacewicz M, Günzel K, Rud E, Sandbæk G, Magheli A, Busch J, et al. Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial. Lancet Infect Dis. 2022;22:1465–71.

Article  CAS  PubMed  Google Scholar 

Hogenhout R, Remmers S, Van Leenders GJLH, Roobol MJ. The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication rates. Prostate Cancer Prostatic Dis. 2023;26:581–7.

Article  PubMed  Google Scholar 

Roberts MJ, Bennett HY, Harris PN, Holmes M, Grummet J, Naber K, et al. Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches. Urology. 2017;104:11–21.

Article  PubMed  Google Scholar 

Study: Transrectal vs transperineal biopsy show similar infection risk [Internet]. 2024. Available from: https://www.urologytimes.com/view/study-transrectal-vs-transperineal-biopsy-show-similar-infection-risk.

Orecchia L, Germani S, Colalillo G, Fasano A, Ricci M, Rosato E, et al. A1060 - Prospective per-target analysis of the added value of probe-tethered access cannulas in cognitive transperineal prostate biopsy of MRI targets. Eur Urol. 2024;85:S2183

Article  Google Scholar 

Bryant RJ, Yamamoto H, Eddy B, Kommu S, Narahari K, Omer A, et al. Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique. BJU Int. 2023;131:694–704.

Article  PubMed  Google Scholar 

Touzani A, Fiard G, Barret E, Renard-Penna R, Salin A, Pradère B, et al. Clinical Trial Protocol for PERFECT: A Randomised Controlled Trial Comparing the Efficiency and Tolerance of Transperineal Fusion Versus Transrectal Imaging-targeted Prostate Biopsies (CCAFU-PR1 Study). Eur Urol Open Sci. 2022;45:76–80.

Article  PubMed  PubMed Central  Google Scholar 

Kaplan-Marans E, Zhang TR, Hu JC. Differing Recommendations on Prostate Biopsy Approach to Minimize Infections: An Examination of the European Association of Urology and American Urological Association Guidelines. Eur Urol. 2023;84:445–6.

Article  PubMed  Google Scholar